Larry Zeitlin Selected Research

2,6- diisopropyl- 4- (1- hydroxy- 2,2,2- trifluoroethyl)phenol

9/2015	Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail.
8/2013	Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail.
10/2012	Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Larry Zeitlin Research Topics

Disease

21	Infections 06/2022 - 07/2002
12	Ebola Hemorrhagic Fever 01/2021 - 10/2012
5	Communicable Diseases (Infectious Diseases) 01/2022 - 02/2014
5	Virus Diseases (Viral Diseases) 01/2022 - 01/2016
3	Fever (Fevers) 01/2021 - 10/2014
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2021 - 04/2002
2	COVID-19 01/2022 - 01/2021
2	American Hemorrhagic Fever (Bolivian Hemorrhagic Fever) 01/2021 - 04/2016
2	Marburg Virus Disease 01/2021 - 10/2020
2	Viremia 12/2019 - 10/2012
2	Rabies (Hydrophobia) 01/2016 - 02/2014
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2022
1	Inflammation (Inflammations) 07/2021
1	Crimean Hemorrhagic Fever 01/2021
1	Neoplasms (Cancer) 01/2021
1	Bacterial Vaginosis 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2020
1	Vesicular Stomatitis 01/2020
1	Pulmonary Edema 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Lymphopenia (Lymphocytopenia) 12/2019
1	Encephalitis (Encephalitis, Rasmussen) 12/2019
1	Bronchiolitis 01/2019
1	Edema (Dropsy) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Primate Diseases 01/2019
1	HIV Infections (HIV Infection) 01/2017
1	Human Influenza (Influenza) 01/2016
1	Respiratory Syncytial Virus Infections 04/2014
1	Anthrax 02/2014
1	Septic Shock (Toxic Shock Syndrome) 07/2012
1	Coinfection 05/2010
1	Herpes Genitalis (Genital Herpes) 04/2002

Drug/Important Bio-Agent (IBA)

22	Monoclonal AntibodiesIBA 01/2022 - 07/2012
11	AntibodiesIBA 01/2021 - 07/2002
6	Glycoproteins (Glycoprotein)IBA 06/2022 - 07/2002
6	VaccinesIBA 01/2022 - 01/2017
3	Broadly Neutralizing AntibodiesIBA 10/2020 - 01/2016
3	AerosolsIBA 01/2019 - 01/2017
3	2,6- diisopropyl- 4- (1- hydroxy- 2,2,2- trifluoroethyl)phenolIBA 09/2015 - 10/2012
2	Biomarkers (Surrogate Marker)IBA 06/2022 - 12/2019
2	remdesivirIBA 01/2022 - 01/2021
2	CytokinesIBA 01/2021 - 01/2020
2	Neutralizing AntibodiesIBA 01/2021 - 10/2020
2	EpitopesIBA 01/2020 - 01/2016
2	Polysaccharides (Glycans)IBA 01/2020 - 11/2018
2	RicinIBA 01/2020 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2018 - 04/2014
2	Anti-Infective Agents (Microbicides)IBA 01/2017 - 04/2002
1	Antigen-Antibody Complex (Immune Complex)IBA 07/2021
1	Complement System Proteins (Complement)IBA 07/2021
1	Ebola VaccinesIBA 01/2021
1	atoltivimabIBA 01/2021
1	SolutionsIBA 01/2021
1	ansuvimabIBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	maftivimabIBA 01/2021
1	odesivimabIBA 01/2021
1	Combined Antibody TherapeuticsIBA 01/2020
1	Immunoglobulin A (IgA)IBA 01/2020
1	ChemokinesIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Investigational DrugsIBA 01/2019
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 11/2018
1	Hemagglutinins (Hemagglutinin)IBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	ZMappIBA 10/2014
1	Palivizumab FDA Link 04/2014
1	Enterotoxins (Enterotoxin)IBA 02/2014
1	staphylococcal enterotoxin BIBA 07/2012
1	Proteins (Proteins, Gene)FDA Link 05/2010
1	Local Anti-Infective Agents (Antiseptics)IBA 04/2002

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2016
1	Contraception (Birth Control) 01/2021
1	Treatment Delay 10/2012